SCHEMBL3829280

SCHEMBL3829280

[CH2]OOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL867 0.72
SCHEMBL20136113 0.67
SCHEMBL27326564 0.67
SCHEMBL27420135 0.67
Water SCHEMBL27550630 0.67
SCHEMBL27257 0.63
SCHEMBL16187035 0.63
Methoxymethane SCHEMBL727682 0.63
Methyl Alcohol SCHEMBL10771823 0.62
Ethylene SCHEMBL540163 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9688643-B2 Triazine derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. (JP) 2017-06-27 US disclosed
US-20160185736-A1 NOVEL, TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME SHIONOGI & CO., LTD. 2016-06-30 US disclosed
US-9150546-B2 Triazine derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. (JP) 2015-10-06 US disclosed
EP-2885292-A1 VEGFR3 INHIBITORS Cancer Therapeutics Crc Pty Limited (AU) 2015-06-24 EP disclosed
WO-2014026242-A1 VEGFR3 INHIBITORS CANCER THERAPEUTICS CRC PTY LIMITED (AU) 2014-02-20 WO disclosed
US-20110319414-A1 NOVEL TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME SHIONOGI & CO., LTD. (JP) 2011-12-29 US disclosed
EP-2399910-A1 NOVEL TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Shionogi&Co., Ltd. (JP) 2011-12-28 EP disclosed
EP-1885703-A4 PROCESSES FOR PRODUCTION OF PHENOLIC 4-BIPHENYLYLAZETIDIN-2-ONES MICROBIA INC (US) 2009-09-02 EP disclosed
US-20090099355-A1 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids MICROBIA, INC. (US) 2009-04-16 US disclosed
US-20080287663-A1 Process For Production Of 4-Biphenylyazetidin-2-Ones MICROBIA, INC. (US) 2008-11-20 US disclosed
EP-1896135-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS Microbia, Inc. (US) 2008-03-12 EP disclosed
EP-1893571-A2 PROCESS FOR PRODUCTION OF 4-BIPHENYLYAZETIDIN-2-ONES Microbia Inc. (US) 2008-03-05 EP disclosed
EP-1885703-A2 PROCESSES FOR PRODUCTION OF PHENOLIC 4-BIPHENYLYLAZETIDIN-2-ONES Microbia, Inc. (US) 2008-02-13 EP disclosed
CN-100360669-C Oligomeric compounds that modulate survivin expression SANTARIS PHARMA AS (DK) 2008-01-09 CN disclosed
WO-2006127893-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS MICROBIA, INC. (US) 2006-11-30 WO disclosed
WO-2006122020-A2 PROCESS FOR PRODUCTION OF 4-BIPHENYLYAZETIDIN-2-ONES MICROBIA, INC. (US) 2006-11-16 WO disclosed
WO-2006122216-A2 PROCESSES FOR PRODUCTION OF PHENOLIC 4-BIPHENYLYLAZETIDIN-2-ONES MICROBIA, INC. (US) 2006-11-16 WO disclosed
CN-1748029-A Oligomeric compounds that modulate survivin expression SANTARIS PHARMA AS (DK) 2006-03-15 CN disclosed
WO-1997001360-A9 COMPOUNDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS AND THEIR USE IN MEDICAL THERAPY AND DIAGNOSIS 1997-07-17 WO disclosed
US-4853403-A 3-phenylthiomethylstyrene derivative, process for preparing the same, and antiallergic agent and tyrosinekinase inhibiting agent containing the same KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1989-08-01 US disclosed